DNA Synthesis Market Size to Surpass USD 20.87 Bn by 2032
10 janv. 2024 11h00 HE
|
Precedence Research
Ottawa, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global DNA synthesis market size is currently valued at more than USD 4.96 billion and is projected to reach USD 14.50 billion by 2030, expanding at a...
Global Enzymatic DNA Synthesis Market Analysis, Trends and Forecasts to 2028 - Opportunities in CRISPR-Cas9 Integration and Cell-Free Synthetic Biology
12 déc. 2023 05h23 HE
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Global Enzymatic DNA Synthesis Market: Analysis By Product Type (DNA Library Synthesis and Custom DNA Synthesis), By Technology (PCR, CRISPR, SOLA and...
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
03 nov. 2023 12h00 HE
|
Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
28 sept. 2023 15h48 HE
|
Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Gene Synthesis Market Size & Share to Surpass $6.58 Billion by 2028 | Vantage Market Research
27 mars 2023 07h02 HE
|
Vantage Market Research
WASHINGTON, March 27, 2023 (GLOBE NEWSWIRE) -- Global Gene Synthesis Market is valued at USD 2.16 Billion in 2021 and is projected to reach USD 6.58 Billion by 2028 at a CAGR (Compound Annual Growth...
Enormous Investments in Biotechnology to Propel the Gene Synthesis Market Grow at 19.2% from 2023 to 2033: Future Market Insights, Inc.
23 janv. 2023 08h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Jan. 23, 2023 (GLOBE NEWSWIRE) -- As per FMI, the gene synthesis market is expected to reach US$ 779.4 million in 2023. Furthermore, the market is projected to record a CAGR of 19.2%...
Telesis Bio Inc. Reports Third Quarter 2022 Financial Results
08 nov. 2022 16h10 HE
|
Telesis Bio
-- Record revenue of $6.7M in 3QFY22; Increase of 140% over $2.8M 3QFY 2021 -- BioXp® Kit Revenue increased to $884k, or 69% in 3QFY22 over 3QFY2021 -- Increases revenue guidance to $23 million to...
Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
12 oct. 2022 09h00 HE
|
Codex DNA, Inc.
SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to...
Codex DNA weitet Anwendung der firmeneigenen Fehlerkorrekturtechnologie aus
04 oct. 2022 09h00 HE
|
Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), ein Pionier im Bereich automatisierter Tischsysteme für die synthetische Biologie, gab heute die Markteinführung der...
Codex DNA étend l'application de la technologie exclusive de correction des erreurs
04 oct. 2022 09h00 HE
|
Codex DNA, Inc.
SAN DIEGO, 04 oct. 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ : DNAY), un pionnier des systèmes de paillasse automatisés de biologie synthétique, a annoncé aujourd'hui le lancement commercial...